Acute antipsychotic-induced akathisia revisited.
Akathisia remains one of the most prevalent and distressful antipsychotic-induced adverse events. Effective and well-tolerated treatment is a major unmet need in akathisia that merits a search for new remedies. Accumulating evidence indicates that agents with marked serotonin-2A receptor antagonism may represent a new class of potential anti-akathisia treatment.
Poyurovsky
Michael
M
D000208:Acute Disease; D017109:Akathisia, Drug-Induced / Q000188:drug therapy / Q000209:etiology*; D014150:Antipsychotic Agents / Q000009:adverse effects*; D006801:Humans; D008803:Mianserin / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D000078785:Mirtazapine; D017410:Practice Guidelines as Topic; D058830:Serotonin 5-HT2 Receptor Antagonists
D014150:Antipsychotic Agents; D058830:Serotonin 5-HT2 Receptor Antagonists; D008803:Mianserin; D000078785:Mirtazapine